Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation. | Thromb J | 2023 | 36890543 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Exploring the targeting spectrum of rocaglates among eIF4A homologs. | RNA | 2023 | 36882295 | PubTator, text mining | PubMed |
| LncRNA HOTAIRM1 functions in DNA double-strand break repair via its association with DNA repair and mRNA surveillance factors. | Nucleic Acids Res | 2023 | 36881772 | PubTator, text mining | PubMed |
| Prenatal alcohol exposure results in brain region- and sex-specific changes in circHomer1 expression in adult mouse brain. | Front Neurosci | 2023 | 36875647 | PubTator, text mining | PubMed |
| SpliceTools, a suite of downstream RNA splicing analysis tools to investigate mechanisms and impact of alternative splicing. | Nucleic Acids Res | 2023 | 36864749 | PubTator, text mining | PubMed |
| Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. | Signal Transduct Target Ther | 2023 | 36864020 | PubTator, text mining | PubMed |
| Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6. | Cell Transplant | 2023 | 36852700 | PubTator, text mining | PubMed |
| The eukaryotic translation initiation factor eIF4E reprograms alternative splicing. | EMBO J | 2023 | 36843541 | PubTator, text mining | PubMed |
| Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 36834627 | PubTator, text mining | PubMed |
| Nonsense-Mediated mRNA Decay as a Mediator of Tumorigenesis. | Genes (Basel) | 2023 | 36833284 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. | Cancers (Basel) | 2023 | 36831450 | PubTator, text mining | PubMed |
| Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis. | Comput Math Methods Med | 2023 | 36820319 | PubTator, text mining | PubMed |
| Proteomics comparison between mass-like and non-mass-like breast lesions. | Ann Transl Med | 2023 | 36819556 | PubTator, text mining | PubMed |
| Hypoxia-Induced FUS-circTBC1D14 Stress Granules Promote Autophagy in TNBC. | Adv Sci (Weinh) | 2023 | 36806670 | PubTator, text mining | PubMed |
| Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages. | J Exp Clin Cancer Res | 2023 | 36797769 | PubTator, text mining | PubMed |
| Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma. | Chin Med J (Engl) | 2023 | 36780420 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs as Novel Targets for Phytochemicals to Cease Cancer Metastasis. | Molecules | 2023 | 36770654 | PubTator, text mining | PubMed |
| UPF1-From mRNA Degradation to Human Disorders. | Cells | 2023 | 36766761 | PubTator, text mining | PubMed |
| Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling. | J Nanobiotechnology | 2023 | 36755314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=18